This was the stock's third consecutive day of gains.

Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with ...

In this free download, shed some light on the latest developments in photoredox for drug development and materials science ...

Apple's Advanced Data Protection for iCloud feature uses end-to-end encryption to provide the highest level of cloud data security that Apple offers. Here's everything you need to know about ...

White piedra is a superficial fungal infection of the hair. Several species of fungus that live in soil or dirty water can cause it. Piedra is the Spanish word for stone. White piedra appears as ...

On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...

The original design featured the word “Google” in colourful, primary hues set against a white background. Primary colours projected the company's vibrant culture and diverse offerings, spanning search ...

(Reuters) -Merck said on Tuesday it would not ship its HPV vaccine Gardasil in China until at least the middle of this year due to weak discretionary spending, a move that dented its full-year ...

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey · Reuters Michael Erman and Mariam Sunny Updated Tue, Feb 4, 2025, 7:21 AM 3 min read ...

Merck (MRK) is down -10.8%, or -$10.74 to $89.05. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing ...